Now showing items 1-5 of 5

  • Characteristics of and differences between Pasifika women and New Zealand European women diagnosed with breast cancer in New Zealand

    Brown, Charis; Lao, Chunhuan; Lawrenson, Ross; Tin Tin, Sandar; Schaaf, Michelle; Kidd, Jacquie; Allan-Moetaua, Anne; Herman, Josephine; Raamsroop, Reena; Campbell, Ian; Elwood, Mark (2017)
    AIM: Breast cancer in New Zealand-based Pasifika women is a significant issue. Although Pasifika women have a lower incidence of breast cancer compared to New Zealand European women, they have higher breast cancer mortality ...
  • Ethnic disparities in breast cancer survival in New Zealand: which factors contribute?

    Tin Tin, Sandar; Elwood, J. Mark; Brown, Charis; Sarfati, Diana; Campbell, Ian; Scott, Nina; Ramsaroop, Reena; Seneviratne, Sanjeewa; Harvey, Vernon; Lawrenson, Ross (BioMed central, 2018)
    Background: New Zealand has major ethnic disparities in breast cancer survival with Maori (indigenous people) and Pacific women (immigrants or descended from immigrants from Pacific Islands) faring much worse than other ...
  • Obesity and breast cancer outcomes in chemotherapy patients in New Zealand - a population-based cohort study

    Elwood, J. Mark; Tin Tin, Sandar; Kuper-Hommel, Marion; Lawrenson, Ross; Campbell, Ian (BMC, 2018)
    Background: Obesity has been reported as an adverse prognostic factor in breast cancer, but inconsistently, and under-treatment with chemotherapy may occur. We provide the first assessment of obesity and breast cancer ...
  • Urban Rural Differences in Breast Cancer in New Zealand

    Lawrenson, Ross; Lao, Chunhuan; Elwood, Mark; Brown, Charis; Sarfati, Diana; Campbell, Ian (MDPI AG, 2016)
    Many rural communities have poor access to health services due to a combination of distance from specialist services and a relative shortage of general practitioners. Our aims were to compare the characteristics of urban ...
  • The use of trastuzumab in New Zealand women with breast cancer

    Lawrenson, Ross; Lao, Chunhuan; Campbell, Ian; Harvey, Vernon; Brown, Charis; Seneviratne, Sanjeewa; Edwards, Melissa; Elwood, Mark; Kuper-Hommel, Marion (Wiley, 2017)
    Aim Trastuzumab was first funded in New Zealand for use in HER2+ve stage I–III breast cancer in 2007. This observational study aims to ascertain the patterns of use of trastuzumab in women with invasive HER2+ve breast ...